Research Summary The BPC-157/TB-500/GHK-Cu/KPV peptide blend leverages synergistic mechanisms to promote tissue repair and reduce inflammation, with evidence primarily from preclinical animal models
A 2007 double-blind, multicenter trial (n=102) showed ALC 1,500 mg/day significantly improved tender point count, total myalgic score, depression, and musculoskeletal pain compared to placebo.[9] A 2015 RCT found ALC 1,500 mg/day comparable to duloxetine 60 mg/day for pain and depression.[8] Most notably, a 2023 RCT demonstrated that adding PEA 1,200 mg/day + ALC 2,000 mg/day to ongoing duloxetine + pregabalin therapy produced significantly greater improvements in Widespread Pain Index, FIQR, and FASmod scores.[7] Role in Treatment: ALC can be used as monotherapy or adjunctive therapy in fibromyalgia
Drug and toxin metabolism
What can one expect from L-Carnitine supplementation
Naturally present in every cell, it is a peptide molecule composed of three amino acids: glutamine, cysteine, and glycine
After combining genes with medical history, the group could sort people into meaningfully different response groups